Ascend Advanced Therapies

Philadelphia, PA
AAV Lentiviral Plasmid
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
78.1
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (1) ○ MHRA GMP

Quick Facts: Ascend Advanced Therapies

Signal Score
78.1/100 (as of 2026-04-29)
Quality Compliance
100.0/100 — No FDA inspection records found for this manufacturer
Headquarters
Philadelphia, PA
Modalities
AAV, Lentiviral, Plasmid
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Ascend Advanced Therapies

Spun out of former Spark Therapeutics manufacturing team.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates1 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100
Sites: Philadelphia, PA
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100

Ascend Advanced Therapies EMA GMP Compliance 1 certificates

2024-09
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DE_BY_04_GMP_2025_0088 Ascend Advanced Therapies GmbH Germany 2024-09-19 COMPLIANT
Source: EMA EudraGMDP · Retrieved May 24, 2026

Frequently Asked Questions About Ascend Advanced Therapies

Does Ascend Advanced Therapies hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 EMA GMP certificate for Ascend Advanced Therapies.
What is Ascend Advanced Therapies's CDMO Signal Score?
Ascend Advanced Therapies has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Ascend Advanced Therapies for a manufacturing program?
Use the free AI matchmaker to compare Ascend Advanced Therapies against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Plasmid CDMOs →

Similar CDMOs

Center for Breakthrough Medicines
King of Prussia, PA
Signal Score: 59.0
AAV, Lentiviral, Plasmid
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid
Yposkesi (SK Pharmteco)
Corbeil-Essonnes, France
Signal Score: 80.3
AAV, Lentiviral, Plasmid